Treatment Patterns and Patient Characteristics Among Early Initiators of PCSK9 Inhibitors

Vascular Health and Risk Management
doi 10.2147/vhrm.s180496
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Real World Treatment Patterns of PCSK9 Inhibitors Among Patients With Dyslipidemia in Germany, Spain, and United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Successful Treatment of a Patient With Refractory Nephrotic Syndrome With PCSK9 Inhibitors: A Case Report

BMC Nephrology
Nephrology
2017English

Natural History of Bleeding and Characteristics of Early Bleeders Among Warfarin Initiators &Ndash; A Cohort Study in Finland

Clinical Epidemiology
Epidemiology
2016English

PCSK9 Peptide Inhibitors

Science-Business eXchange
2014English

Early Treatment of Patient With Class III Skeletal and Dental Patterns

Dental Press Journal of Orthodontics
Oral SurgeryOrthodontics
2015English

Are PCSK9 Inhibitors Cost Effective?

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2018English

Constipation in Early Childhood: Patient Characteristics, Treatment, and Longterm Follow Up.

Gut
Gastroenterology
1993English

PCSK9 Inhibitors: When Statins Aren't Enough

Prescriber
Pharmacology
2017English

PCSK9 Inhibitors: A Technology Worth Paying For?

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy